Hippocampal estrogen beta-receptor immunoreactivity is increased in Alzheimer's disease

Citation
E. Savaskan et al., Hippocampal estrogen beta-receptor immunoreactivity is increased in Alzheimer's disease, BRAIN RES, 908(2), 2001, pp. 113-119
Citations number
30
Categorie Soggetti
Neurosciences & Behavoir
Journal title
BRAIN RESEARCH
ISSN journal
00068993 → ACNP
Volume
908
Issue
2
Year of publication
2001
Pages
113 - 119
Database
ISI
SICI code
0006-8993(20010727)908:2<113:HEBIII>2.0.ZU;2-I
Abstract
Post-menopausal estrogen use reduces the risk and severity of Alzheimer's d isease (AD). The present study investigates the distribution of both estrog en receptors ER alpha and ER beta in the human hippocampus in aged controls and in AD cases with immunohistochemistry. No ER alpha immunoreactivity wa s observed both in controls and in AD cases. On the other hand, ER beta was observed in some neuronal cells in the hippocampal subfields CA1-4, in ast rocytes and in extracellular deposits both in controls and AD cases. The ER beta immunoreactivity was distinctly increased in all AD cases in cellular and extracellular localizations indicating a role for ER beta -mediated es trogen effects in AD-related neuropathology. This study provides the first demonstration of ER beta in human hippocampus in aged controls compared to AD cases. (C) 2001 Elsevier Science B.V. All rights reserved.